Latest filings (excl ownership)
15-12B
Securities registration termination
29 Jul 19
EFFECT
Notice of effectiveness
22 Jul 19
EFFECT
Notice of effectiveness
22 Jul 19
25-NSE
Exchange delisting
18 Jul 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Jul 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Jul 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Jul 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Jul 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Jul 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Jul 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Jul 19
POS AM
Prospectus update (post-effective amendment)
18 Jul 19
POS AM
Prospectus update (post-effective amendment)
18 Jul 19
8-K
Completion of Acquisition or Disposition of Assets
18 Jul 19
8-K
Aratana Therapeutics’ Stockholders Adopt Merger Agreement with Elanco Animal Health
16 Jul 19
8-K
Other Events
2 Jul 19
425
Business combination disclosure
2 Jul 19
DEFM14A
Proxy related to merger
17 Jun 19
8-K
Submission of Matters to a Vote of Security Holders
7 Jun 19
425
Business combination disclosure
29 May 19
425
Business combination disclosure
9 May 19
10-Q
2019 Q1
Quarterly report
9 May 19
8-K
Aratana Therapeutics Reports First Quarter 2019 Financial Results
8 May 19
425
Business combination disclosure
7 May 19
425
Business combination disclosure
30 Apr 19
425
Business combination disclosure
30 Apr 19
425
Business combination disclosure
26 Apr 19
425
Business combination disclosure
26 Apr 19
8-K
Aratana Therapeutics to be Acquired by Elanco Animal Health
26 Apr 19
425
Business combination disclosure
26 Apr 19
425
Business combination disclosure
26 Apr 19
DEFA14A
Additional proxy soliciting materials
19 Apr 19
DEF 14A
Definitive proxy
19 Apr 19
8-K
Departure of Directors or Certain Officers
15 Mar 19
S-8
Registration of securities for employees
13 Mar 19
10-K
2018 FY
Annual report
13 Mar 19
8-K
Aratana Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
12 Mar 19
UPLOAD
Letter from SEC
11 Feb 19
8-K
Departure of Directors or Certain Officers
5 Feb 19
8-K
Departure of Directors or Certain Officers
22 Jan 19
Latest ownership filings
SC 13G
Aratana Therapeutics, Inc.
29 Jul 19
4
KEVIN KOTLER
22 Jul 19
SC 13G/A
Aratana Therapeutics, Inc.
22 Jul 19
4
WENDY L YARNO
18 Jul 19
4
Vort John Vander
18 Jul 19
4
CRAIG A TOOMAN
18 Jul 19
4
ROBERT P ROCHE JR
18 Jul 19
4
LOWELL W ROBINSON
18 Jul 19
4
CHRISTOPHER T READY
18 Jul 19
4
MERILEE RAINES
18 Jul 19
4
Irvine O Hockaday Jr
18 Jul 19
4
RHONDA LYNETTE HELLUMS
18 Jul 19
4
ERNST HEINEN
18 Jul 19
4
David L Brinkley
18 Jul 19
4
Craig A. Barbarosh
18 Jul 19
4
JOHN C AYRES
18 Jul 19
4
WENDY L YARNO
7 Jun 19
4
Vort John Vander
7 Jun 19
4
ROBERT P ROCHE JR
7 Jun 19
4
LOWELL W ROBINSON
7 Jun 19
4
MERILEE RAINES
7 Jun 19
4
Irvine O Hockaday Jr
7 Jun 19
4
David L Brinkley
7 Jun 19
4
Craig A. Barbarosh
7 Jun 19
SC 13G/A
Aratana Therapeutics, Inc.
8 Feb 19
4
RHONDA LYNETTE HELLUMS
5 Feb 19
3
RHONDA LYNETTE HELLUMS
5 Feb 19
SC 13G/A
Aratana Therapeutics, Inc.
4 Feb 19
4
JOHN C AYRES
1 Feb 19
4
CRAIG A TOOMAN
28 Jan 19
4
CHRISTOPHER T READY
28 Jan 19
4
ERNST HEINEN
28 Jan 19
4
JOHN C AYRES
28 Jan 19
SC 13G/A
Aratana Therapeutics, Inc.
25 Jan 19
SC 13G/A
Aratana Therapeutics, Inc.
22 Jan 19
3
KEVIN KOTLER
22 Jan 19
SC 13D/A
Aratana Therapeutics, Inc.
10 Jan 19
3
CHRISTOPHER T READY
9 Jan 19
3
JOHN C AYRES
9 Jan 19
4
Peter Steven St
17 Dec 18